keyword
https://read.qxmd.com/read/38599660/defining-d-iraes-consensus-based-disease-definitions-for-the-diagnosis-of-dermatologic-adverse-events-from-immune-checkpoint-inhibitor-therapy
#21
JOURNAL ARTICLE
Steven T Chen, Yevgeniy R Semenov, Allireza Alloo, Daniel Q Bach, Allison Betof Warner, Amina Bougrine, Leeann Burton, Laura C Cappelli, Mariana Castells, Justine Cohen, Anna K Dewan, Riley Fadden, Lauren Guggina, Aparna Hegde, Victor Huang, Douglas B Johnson, Benjamin Kaffenberger, Daniela Kroshinsky, Shawn Kwatra, Bernice Kwong, Mario E Lacouture, Cecilia Larocca, Jonathan Leventhal, Alina Markova, Jon McDunn, Meghan J Mooradian, Jarushka Naidoo, Jennifer Choi, Vinod Nambudiri, Caroline A Nelson, Anisha B Patel, Julia Pimkina, Johnathan Rine, Krista M Rubin, Maxwell Sauder, Sheila Shaigany, Afreen Shariff, Ryan J Sullivan, Leyre Zubiri, Kerry L Reynolds, Nicole R LeBoeuf
With an increasing number of patients eligible for immune checkpoint inhibitors, the incidence of immune-related adverse events (irAEs) is on the rise. Dermatologic immune-related adverse events (D-irAEs) are the most common and earliest to manifest, often with important downstream consequences for the patient. Current guidelines lack clarity in terms of diagnostic criteria for D-irAEs. The goal of this project is to better define D-irAE for the purposes of identification, diagnosis, and future study of this important group of diseases...
April 10, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38598171/current-diagnostic-and-therapeutic-practices-in-alopecia-areata-in-two-mediterranean-countries-a-survey-based-study
#22
JOURNAL ARTICLE
Michela Starace, Francesca Pampaloni, Elisabeth Lazaridou, Eirini Kyrmanidou, Alexander Stratigos, Aimilios Lallas, Alexander Katoulis, Dimitrios Sgouros, Federico Quadrelli, Luca Rapparini, Stephano Cedirian, Francesca Bruni, Lorenzo Ala, Alfredo Rossi, Bianca Maria Piraccini, Zoe Apalla
INTRODUCTION: Alopecia areata (AA) affects approximately 2% of the general population and is associated with significant psychosocial morbidity and poor health-related quality of life. Despite the high incidence of the disease the available clinical practice guidelines to help clinicians and improve patients' care are very poor and of a low methodological quality, as compared to other high-burden dermatoses. The aim of this survey is to capture the current clinical practice in AA management, as performed by dermatologists, in two Mediterranean countries to identify potential disparities and gaps in diagnosis and treatment...
April 10, 2024: Dermatology and Therapy
https://read.qxmd.com/read/38576248/skin-barrier-function-assessment-electrical-impedance-spectroscopy-is-less-influenced-by-daily-routine-activities-than-transepidermal-water-loss
#23
JOURNAL ARTICLE
Lisa Huygen, Pauline Marie Thys, Andreas Wollenberg, Jan Gutermuth, Inge Kortekaas Krohn
BACKGROUND: Skin barrier function assessment is commonly done by measuring transepidermal water loss (TEWL). An important limitation of this method is the influence of intrinsic and extrinsic factors. Electrical impedance spectroscopy (EIS) is a lesser-established method for skin barrier function assessment. Some influential factors have been described, but no guidelines exist regarding the standardization of these measurements. OBJECTIVE: To evaluate the effect size of daily routine activities on TEWL and EIS, as well as their correlation with age and anatomical differences...
April 2024: Annals of Dermatology
https://read.qxmd.com/read/38576226/aesthetic-doctors-perception-and-attitudes-toward-tolerance-in-botulinum-toxin
#24
JOURNAL ARTICLE
Seung Min Oh, Hyoung Moon Kim, Tae Hwan Ahn, Min Soo Park, Yoo-Seock Ree, Eun Soo Park
BACKGROUND: Botulinum toxin is a crucial therapeutic tool with broad indications in both cosmetic and medical fields. However, the expanding cosmetic use and increased dosages of botulinum toxin have raised concerns about resistance, making it essential to study the awareness and management practices among healthcare professionals. METHODS: A survey was conducted among clinical physicians using botulinum toxin. The study investigated their experiences, awareness, and management practices related to toxin resistance...
April 2024: Skin Research and Technology
https://read.qxmd.com/read/38572024/quality-of-life-in-psoriasis-a-cross-sectional-study-from-north-india
#25
JOURNAL ARTICLE
Khushboo Arora, Neirita Hazarika, Ranjeeta Kumari, Himanshu Chawla
BACKGROUND: Psoriasis is a chronic inflammatory papulo-squamous disease characterized by multiple remissions and relapses. This study aimed to assess the impact of psoriasis on the quality of life of patients. MATERIALS AND METHODS: A hospital-based, cross-sectional study was conducted enrolling 198 adult patients of psoriasis. The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for observational studies were followed. Clinical severity of psoriasis was measured using Psoriasis Area Severity Index (PASI), and quality of life was measured by EuroQoL 5D (EQ-5D-5L, EQ-VAS) and Psoriasis Quality-Of-Life-12 (PQOL-12) Questionniares...
2024: Indian Journal of Dermatology
https://read.qxmd.com/read/38571931/chinese-guideline-for-the-diagnosis-and-treatment-of-takayasu-s-arteritis-2023
#26
REVIEW
Xinping Tian, Xiaofeng Zeng
Takayasu's arteritis (TAK) is a chronic granulomatous inflammatory disease that involves aorta and its primary branches. It is characterized by wall thickening, stenosis/obliteration or aneurysm formation of the involved arteries. In order to standardize the diagnosis and treatment of TAK in China, a clinical practice guideline with an evidence-based approach is developed under the leadership of National Clinical Medical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID). Eleven recommendations for 11 clinical questions that are important to the diagnosis and treatment of TAK are developed based on the latest evidence and expert opinions combined with real clinical practice in China...
March 2024: Rheumatol Immunol Res
https://read.qxmd.com/read/38570376/large-language-and-vision-assistant-in-dermatology-a-game-changer-or-just-hype
#27
JOURNAL ARTICLE
Polat Goktas, Duygu Gülseren, Anne-Marie Tobin
The integration of artificial intelligence (AI) in healthcare, particularly in the field of dermatology, has experienced significant progress through the creation of advanced tools such as the Large Language and Vision Assistant (LLaVA). This comprehensive review examines whether LLaVA represents a significant breakthrough or merely a passing trend in dermatological practice. By incorporating both language and visual analysis capabilities, LLaVA aims to support enhanced diagnostic accuracy, patient engagement, and customized treatment planning, as evidenced by current research and case studies...
April 4, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38569598/a-systematic-review-investigating-the-proportion-of-clinical-images-shared-in-prospective-randomized-controlled-trials-involving-patients-with-atopic-dermatitis-and-systemic-pharmacotherapy
#28
REVIEW
Sam Polesie, Mikael Alsterholm
For individuals with atopic dermatitis (AD), interpreting scientific papers that present clinical outcomes including the Eczema Area and Severity Index (EASI) and Investigators Global Assessment may be difficult. When compared to tabulated data and graphs, images from before and after treatment are often far more meaningful to these patients that ultimately will be candidates for the treatment. This systematic review focused on determining the frequency of clinical image sharing in AD research. Conducted in accordance with PRISMA guidelines, the review concentrated on randomized controlled trials that investigated predefined and available systemic treatments for AD...
December 2024: Journal of Dermatological Treatment
https://read.qxmd.com/read/38568616/barriers-and-facilitators-affecting-long-term-antibiotic-prescriptions-for-acne-treatment
#29
JOURNAL ARTICLE
Ronnie A Festok, Avni S Ahuja, Jared Y Chen, Lena Chu, Jason Barron, Katherine Case, Elaine Thompson, Suephy C Chen, Jonathan Weiss, Robert A Swerlick, Cam Escoffery, Howa Yeung
IMPORTANCE: Dermatologists prescribe more oral antibiotics per clinician than clinicians in any other specialty. Despite clinical guidelines that recommend limitation of long-term oral antibiotic treatments for acne to less than 3 months, there is little evidence to guide the design and implementation of an antibiotic stewardship program in clinical practice. OBJECTIVE: To identify salient barriers and facilitators to long-term antibiotic prescriptions for acne treatment...
April 3, 2024: JAMA Dermatology
https://read.qxmd.com/read/38568509/human-leukocyte-antigens-and-sulfamethoxazole-cotrimoxazole-induced-severe-cutaneous-adverse-reactions-a-systematic-review-and-meta-analysis
#30
JOURNAL ARTICLE
Po-Chien Wu, Wei-Ti Chen, I-Hsin Huang, Chun-Bing Chen, Chuang-Wei Wang, Cheng-Chen Tai, Wen-Hung Chung, Ching-Chi Chi
IMPORTANCE: Sulfamethoxazole (SMX) and cotrimoxazole (CTX), a fixed-dose combination of SMX and trimethoprim in a 5:1 ratio, are antibacterial sulfonamides commonly used for treating various diseases. A substantial prevalence of severe cutaneous adverse reactions (SCARs) following the administration of these drugs has been reported. However, the association between human leukocyte antigen (HLA) genotypes and SMX/CTX-induced SCARs has remained unclear. OBJECTIVE: To investigate the association between HLA genotypes and SMX/CTX-induced SCARs...
April 3, 2024: JAMA Dermatology
https://read.qxmd.com/read/38566531/a-qualitative-tool-to-guide-in-the-interpretation-of-the-numerical-rating-scale-for-pruritus-intensity-in-patients-with-atopic-dermatitis
#31
JOURNAL ARTICLE
Ignasi Figueras, Marta Feito, Marta García-Bustinduy, Emilio Monte-Boquet, Sandra Ros, Violeta Zaragoza, África Luca de Tena, Francisco Javier Ortiz de Frutos
Atopic dermatitis is a cutaneous inflammatory disease characterized by intense pruritus, which is often underestimated despite its direct impact on patients' health-related quality of life and the high burden it poses. The authors' goal was to design a qualitative tool to guide patients and healthcare professionals in their assessment and interpretation of pruritus intensity using a numerical rating scale. The draft of this tool, henceforth "guideline", was developed based on a systematic literature review and focus groups comprising patients and a scientific committee...
April 2, 2024: Acta Dermato-venereologica
https://read.qxmd.com/read/38565205/successful-treatment-of-recalcitrant-generalized-pustular-psoriasis-of-pregnancy-with-spesolimab
#32
JOURNAL ARTICLE
Chenxin Yang, Yang Wang, Ruoyu Li, Ping Tu, Ruojun Wang
Generalized pustular psoriasis (GPP) in pregnancy can lead to severe complications for both mother and fetus. The treatment of this disease is challenging, especially in recalcitrant and severe cases. Until present, there are no evidence-based guidelines for the treatment of GPP in pregnancy. Spesolimab, a human monoclonal antibody against the IL-36 receptor, has recently attracted attention as a new therapy for GPP flare. This biologic provides rapid and sustained control of symptoms of GPP flare, although its use in pregnant women has not been reported to date...
December 2024: Journal of Dermatological Treatment
https://read.qxmd.com/read/38564397/dermatologists-perspectives-on-biosimilars
#33
JOURNAL ARTICLE
Priscila Arellano Zameza, Christina Kontzias, Keith Flanders, Peter Sonnenreich, Steven R Feldman
Biosimilars are biologic agents the Food and Drug Administration (FDA) has deemed to have no clinical difference from their reference biologics. In dermatology,  biosimilars are approved for the treatment of psoriasis and hidradenitis suppurativa. Although dermatologists are high prescribers of biologics, they are more reluctant to prescribe biosimilars than other specialists. This survey-based study sought to characterize dermatologists’ current perspectives on biosimilars.  Methods: A 27-question survey was distributed via email to dermatologists between September and October of 2022...
April 1, 2024: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/38563446/prognostic-significance-of-sentinel-lymph-node-biopsy-in-elderly-with-cutaneous-melanoma-systematic-review-and-meta-analysis
#34
REVIEW
Nieves Martínez Campayo, Sabela Paradela de la Morena, Sonia Pértega-Díaz, Antonio Tejera Vaquerizo, Eduardo Fonseca
Sentinel lymph node biopsy is the most powerful prognostic indicator to date for cutaneous melanoma. Even though elderly patients have a lower incidence of sentinel node involvement, its results are still necessary for access to adjuvant therapies. This is highly relevant considering that the Western population shows an aging trend, and the incidence of melanoma has grown exponentially over the years, making elderly patients more likely to die from melanoma than younger ones. We performed a systematic review to investigate the prognostic significance of sentinel lymph node biopsy in elderly patients with melanoma...
April 2, 2024: International Journal of Dermatology
https://read.qxmd.com/read/38557456/correlation-between-the-systemic-immune-inflammation-index-and-risk-of-psoriasis-results-from-nhanes
#35
JOURNAL ARTICLE
Jingyi Ma, Xin Sun, Ze Wu, Ruiqun Qi, Jun Niu
The systemic immune inflammation index (SII) is an effective indicator of systemic inflammatory status. As psoriasis patients present with systemic involvement, we assessed whether SII is associated with psoriasis in adults. We used data from the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2006 and 2009 to 2014. The study used a multistage sampling design that nationally represents the US population. The main outcome was the prevalence of psoriasis. SII was calculated as platelet count × neutrophil count/lymphocyte count and transformed into log2SII...
February 1, 2024: European Journal of Dermatology: EJD
https://read.qxmd.com/read/38557455/a-systematic-review-of-the-risk-of-cutaneous-malignancy-associated-with-ultraviolet-nail-lamps-what-is-the-price-of-beauty
#36
JOURNAL ARTICLE
Dea Metko, Shanti Mehta, Eric Mcmullen, E Dimitra Bednar, Mohannad Abu-Hilal
Gel manicures have become part of a popular personal care service in the last two decades due to increased longevity of the polish and the added strength to the nail plate. Prolonged exposure to nail ultraviolet (UV) lamps is required to cure the gel polish. Despite the increased use of UV nail lamps, there is limited consensus in the literature on the risk of skin malignancy associated with UV nail lamps. The objective of this article was to provide a systematic review of the risk of skin malignancy associated with the use of UV nail lamps and to synthesize evidence-based recommendations on their safe usage...
February 1, 2024: European Journal of Dermatology: EJD
https://read.qxmd.com/read/38554588/real-life-management-of-psoriasis-with-biological-agents-during-pregnancy
#37
JOURNAL ARTICLE
C Tran, E Mahé, M Beylot-Barry, D Jullien, M-A Richard, A-C Fougerousse, A Bouznad, C Bulai Livideanu, A Brun, F Amelot, F Maccari, F Aubin, F Benhadou, C Paul
BACKGROUND: French guidelines recommend stopping biologic treatment of psoriasis between 3 and 24 weeks before conception in accordance with the relevant Summary of Product Characteristics (SmPC). The aim of this study was to evaluate the real-life practice of dermatologists in the management of pregnant women with psoriasis previously treated with biologic agents. We wished to assess the level of practitioner adherence to the relevant SmPCs. MATERIAL AND METHODS: We conducted a study in collaboration with GRPso and Resopso...
March 29, 2024: Annales de Dermatologie et de Vénéréologie
https://read.qxmd.com/read/38550843/nail-society-of-india-recommendations-for-treatment-of-onychomycosis-in-special-population-groups
#38
REVIEW
Khushbu Mahajan, Chander Grover, Vineet Relhan, Sushil Tahiliani, Archana Singal, Manjunath M Shenoy, Deepak Jakhar, Shikha Bansal
Onychomycosis (OM) is a difficult-to-treat condition, especially considering the limited armamentarium of antifungal drugs, need for prolonged treatment, and poor compliance. This problem is further confounded while treating OM in special populations such as children, elderly, immunosuppressed patients, pregnant or lactating women, and patients with chronic liver or kidney disease. In the absence of standardized treatment guidelines, the antifungal therapy is either withheld or compromised, as it is largely governed by personal preferences or based on anecdotal reports...
2024: Indian Dermatology Online Journal
https://read.qxmd.com/read/38550804/prescribing-patterns-in-the-treatment-of-topical-steroid-damaged-face-patients-a-cross-sectional-survey-based-observational-study-among-practicing-dermatologists-in-an-eastern-state-of-india
#39
JOURNAL ARTICLE
Chinmoy Raj, Maitreyee Panda, Bhabani S T P Singh, Bikash R Kar, Nibedita Patro
INTRODUCTION: Topical steroid damaged face (TSDF) is a common occurrence in the current scenario, where darker - skinned people believe having lighter-colored skin improves their prospects in all aspects of life. This has led to the abuse of topical corticosteroids with unrealistic expectations driven by ignorance of the adverse effects, particularly in the Indian population. As TSDF is virtually an epidemic in India and there is no treatment protocol for dermatologists, we conducted this study to find out what dermatologists prescribe and, in turn, serve as a foundation to develop guidelines in the future...
2024: Indian Dermatology Online Journal
https://read.qxmd.com/read/38548170/cutaneous-hypersensitivity-reactions-to-immune-checkpoint-inhibitors
#40
JOURNAL ARTICLE
Ryan Storgard, Alina Markova
The introduction of immune checkpoint inhibitors (ICIs) has transformed the management of various malignancies. Alongside their therapeutic success, the widespread application of ICIs has unveiled a spectrum of immune-related adverse events (irAE), most often affecting the skin. Cutaneous irAEs (cirAE) encompass a range from common morbilliform and lichenoid rashes to more severe conditions such as bullous dermatoses and psoriasiform eruptions, each presenting distinct clinical challenges. Moreover, less common but clinically severe cutaneous reactions like toxic epidermal necrolysis have also been observed...
March 26, 2024: Journal of Allergy and Clinical Immunology in Practice
keyword
keyword
105063
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.